Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

  • ID: 4399401
  • Report
  • Region: Global
  • 211 Pages
  • Markets and Markets
1 of 6
The Global Liquid Biopsy Market is Estimated to Grow at a CAGR of 23.4% from 2017 to 2022, to Reach USD 2,047.9 Million By 2022.

FEATURED COMPANIES

  • Biocept, Inc.
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Mdxhealth Sa
  • Myriad Genetics, Inc
  • MORE

“Global liquid biopsy market projected to grow at a CAGR of 23.4%

Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market. Unclear Regulatory and reimbursement scenario is one of the major challenges faced by the market.

“Extracellular vesicles to register the highest CAGR during the forecast period”

Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs) and other circulating biomarkers. The extracellular vesicles segment is the fastest-growing segment in the circulating biomarkers market during the forecast period. This is due to the growing interest in EV research from biofluids such as the blood and urine of cancer patients as a means of disease diagnosis and therapeutic monitoring.

“The non-cancer application segment is projected to grow at the highest CAGR during the forecast period”

Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ transplant diagnostics). The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period. This is due to the growing application in noninvasive prenatal testing (NIPT), using cell-free DNA assays in the identification of trisomies (which includes 13, 16, and 18), gender identification, and other genetic abnormalities such as monosomy X and microdeletions. NIPT is also rapidly replacing amniocentesis in high-risk pregnancies, thus expanding its application.

“Asia Pacific to witness the highest growth during the forecast period (2017-2022)”

North America is expected to account for the largest share of the global liquid biopsy market in 2017, while Asia Pacific is expected to witness the highest growth during 2017 to 2022. Growing demand for non-invasive treatment, rising incidence of cancer, and improving healthcare infrastructure are driving the growth of the liquid biopsy market.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1- 15%, Tier 2- 45%, and Tier 3-40%
  • By Designation - C-level- 27%, Director Level-33%, Others-40%
  • By Region - North America-25%, Europe-45%, Asia-Pacific-15%, RoW-15%

Some of the major market players in the liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDxHealth SA (US).

Research Coverage:

The report analyzes the liquid biopsy market and aims at estimating market size and future growth potential of this market based on various segments such as by product, circulating biomarker, clinical application, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global liquid biopsy market. The report analyzes the global liquid biopsy market by product, medical specialty, application, end user, and region
  • Innovation: Detailed insights on upcoming trends and product launches in the global liquid biopsy market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, medical specialty, application, end user, and region
  • Market Diversification: Exhaustive information about growing geographies, recent developments, and investments in the global liquid biopsy market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and capabilities of liquid biopsy devices of leading players in the global market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Biocept, Inc.
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Mdxhealth Sa
  • Myriad Genetics, Inc
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown And Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Liquid Biopsy: Market Overview
4.2 Liquid Biopsy Market, By Clinical Application (2017)
4.3 Liquid Biopsy Market: Geographic Growth Opportunities
4.4 Liquid Biopsy Market: Geographic Mix
4.5 Liquid Biopsy Market: Established Vs. Emerging Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cancer
5.2.1.2 Increasing Preference for Noninvasive Procedures
5.2.1.3 Initiatives Undertaken By Government And Global Health Organizations
5.2.1.4 Technological Advancement to Augment Market Revenues
5.2.1.5 Rising Emphasis On Personalized Medicine
5.2.1.6 Availability of Funding for Liquid Biopsy R&D
5.2.2 Restraints
5.2.2.1 Low Sensitivity And Specificity
5.2.3 Opportunities
5.2.3.1 Growing Interest in Liquid Biopsy
5.2.4 Challenges
5.2.4.1 Unclear Regulatory And Reimbursement Scenario

6 Liquid Biopsy Market, By Product And Service
6.1 Introduction
6.2 Assay Kits
6.3 Instruments
6.4 Services

7 Liquid Biopsy Market, By Circulating Biomarker
7.1 Introduction
7.2 Circulating Tumor Cells
7.3 Circulating Tumor Dna (Ctdna)
7.4 Cell-Free Dna
7.5 Extracellular Vesicles (Evs)
7.6 Other Circulating Biomarkers

8 Liquid Biopsy Market, By Clinical Application
8.1 Introduction
8.2 Early Cancer Screening
8.3 Therapy Selection
8.4 Treatment Monitoring
8.5 Recurrence Monitoring

9 Liquid Biopsy Market, By Application
9.1 Introduction
9.2 Cancer Applications
9.2.1 Lung Cancer
9.2.2 Breast Cancer
9.2.3 Colorectal Cancer
9.2.4 Prostate Cancer
9.2.5 Liver Cancer
9.2.6 Other Cancers
9.3 Non-Cancer Applications
 
10 Liquid Biopsy Market, By End User
10.1 Introduction
10.2 Reference Laboratories
10.3 Hospitals And Physician Laboratories
10.4 Academic And Research Centers
10.5 Other End Users

11 Liquid Biopsy Market, By Region
11.1 Introduction
11.2 North America
11.2.1 Us
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 Uk
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World (Row)

12 Competitive Landscape
12.1 Market Ranking Analysis
 
13 Company Profiles
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
13.1 Biocept, Inc.
13.2 Qiagen N.V.
13.3 Roche Diagnostics
13.4 Bio-Rad Laboratories, Inc.
13.5 Myriad Genetics, Inc
13.6 Menarini-Silicon Biosystems
13.7 Trovagene, Inc.
13.8 Guardant Health, Inc.
13.9 MDXhealth Sa
13.10 Genomic Health, Inc.
13.11 Raindance Technologies, Inc
13.12 Thermo Fisher Scientific Inc.
13.13 Illumina, Inc.
*Details On Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

14 Appendix
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Subscription Portal
14.4 Introducing Rt: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details

List of Tables:
Table 1 Conferences And Awareness Programs On Liquid Biopsy
Table 2 Liquid Biopsy Products Launched in Recent Years
Table 3 Liquid Biopsy Market: Funding (2014 - 2017)
Table 4 Companies Selling/Developing Liquid Biopsy Tests for Oncology, in the US
Table 5 Liquid Biopsy Market, By Product And Service, 2015-2022 (USD Million)
Table 6 Liquid Biopsy Market for Assay Kits, By Country, 2015-2022 (USD Million)
Table 7 Specifications: Ngs And Ddpcr for Cancer Liquid Biopsies
Table 8 Liquid Biopsy Market for Instruments, By Country, 2015-2022 (USD Million)
Table 9 Liquid Biopsy Market for Services, By Country, 2015-2022 (USD Million)
Table 10 Advantages And Limitations of Ctcs, Ctdna, And Exosomes
Table 11 Liquid Biopsy Market, By Circulating Biomarker, 2015-2022 (USD Million)
Table 12 Companies Active in the Ctcs Segment
Table 13 Liquid Biopsy Market for Circulating Tumor Cells, By Country,  2015-2022 (USD Million)
Table 14 Liquid Biopsy Market for Circulating Tumor Dna, By Country,  2015-2022 (USD Million)
Table 15 Liquid Biopsy Market for Cell-Free Dna, By Country, 2015-2022 (USD Million)
Table 16 Liquid Biopsy Market for Extracellular Vesicles, By Country,  2015-2022 (USD Million)
Table 17 Liquid Biopsy Market for Other Circulating Biomarkers, By Country,  2015-2022 (USD Million)
Table 18 Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 19 Liquid Biopsy Market for Early Cancer Screening, By Country/Region,  2015-2022 (USD Thousands)
Table 20 Liquid Biopsy Market for Therapy Selection, By Country/Region,  2015-2022 (USD Million)
Table 21 Liquid Biopsy Market for Treatment Monitoring, By Country/Region,  2015-2022 (USD Million)
Table 22 Liquid Biopsy Market for Recurrence Monitoring, By Country/Region,  2015-2022 (USD Million)
Table 23 Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 24 Liquid Biopsy Market for Cancer Applications, By Country/Region,  2015-2022 (USD Million)
Table 25 Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 26 Liquid Biopsy Market for Lung Cancer, By Country/Region,  2015-2022 (USD Million)
Table 27 Liquid Biopsy Market for Breast Cancer, By Country/Region,  2015-2022 (USD Million)
Table 28 Liquid Biopsy Market for Colorectal Cancer, By Country/Region,  2015-2022 (USD Million)
Table 29 Liquid Biopsy Market for Prostate Cancer, By Country/Region,  2015-2022 (USD Million)
Table 30 Liquid Biopsy Market for Liver Cancer, By Country/Region,  2015-2022 (USD Million)
Table 31 Liquid Biopsy Market for Other Cancers, By Country/Region,  2015-2022 (USD Million)
Table 32 Liquid Biopsy Market for Non-Cancer Applications, By Country/Region, 2015-2022 (USD Million)
Table 33 Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 34 Liquid Biopsy Market for Reference Laboratories, By Country/Region,  2015-2022 (USD Million)
Table 35 Liquid Biopsy Market for Hospitals And Physician Laboratories, By Country/ Region, 2015-2022 (USD Million)
Table 36 Liquid Biopsy Market for Academic And Research Centers, By Country/ Region, 2015-2022 (USD Million)
Table 37 Liquid Biopsy Market for Other End USers, By Country/Region,  2015-2022 (USD Million)
Table 38 Liquid Biopsy Market, By Region, 2015-2022 (USD Million)
Table 39 Estimated New Cases of Cancer in 2017, US
Table 40 North America: Liquid Biopsy Market, By Country, 2015-2022 (USD Million)
Table 41 North America: Liquid Biopsy Market, By Product & Service,  2015-2022 (USD Million)
Table 42 North America: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 43 North America: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 44 North America: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 45 North America: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015-2022 (USD Million)
Table 46 North America: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 47 US: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 48 US: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 49 US: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 50 US: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 51 US: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 52 US: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 53 Overview of the Breast, Cervical, And Colorectal Cancer Screening Programs Across Canada
Table 54 Canada: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 55 Canada: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 56 Canada: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 57 Canada: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 58 Canada: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 59 Canada: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 60 Europe: Liquid Biopsy Market, By Country, 2015-2022 (USD Million)
Table 61 Europe: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 62 Europe: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 63 Europe: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 64 Europe: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 65 Europe: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 66 Europe: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 67 Germany: Liquid Biopsy Market, By Product & Service,  2015-2022 (USD Million)
Table 68 Germany: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 69 Germany: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 70 Germany: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015-2022 (USD Million)
Table 71 Germany: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 72 Germany: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 73 France: Key Market Indicators
Table 74 France: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 75 France: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 76 France: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 77 France: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 78 France: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 79 France: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 80 UK: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 81 UK: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 82 UK: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 83 UK: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 84 UK: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 85 UK: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 86 ROE: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 87 ROE: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 88 ROE: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 89 ROE: Liquid Biopsy Market for Cancer Applications, By Cancer Type,  2015-2022 (USD Million)
Table 90 ROE: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 91 ROE: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 92 Asia Pacific: Liquid Biopsy Market, By Country, 2015-2022 (USD Million)
Table 93 Asia Pacific: Liquid Biopsy Market, By Product & Service,  2015-2022 (USD Million)
Table 94 Asia Pacific: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 95 Asia Pacific: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 96 Asia Pacific: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 97 Asia Pacific: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 98 Asia Pacific: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 99 Japan: Key Market Indicators
Table 100 Japan: Liquid Biopsy Market, By Product & Service,  2015-2022 (USD Million)
Table 101 Japan: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 102 Japan: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 103 Japan: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 104 Japan: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 105 Japan: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 106 China: Key Market Indicators
Table 107 China: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 108 China: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 109 China: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 110 China: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 111 China: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 112 China: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 113 India: Key Market Indicators:
Table 114 India: Liquid Biopsy Market, By Product & Service,  2015-2022 (USD Million)
Table 115 India: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 116 India: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 117 India: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 118 India: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 119 India: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 120 ROAPAC: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 121 ROAPAC: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 122 ROAPAC: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 123 ROAPAC: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 124 ROAPAC: Liquid Biopsy Market, By Clinical Application,  2015-2022 (USD Million)
Table 125 ROAPAC: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 126 ROW: Liquid Biopsy Market, By Product & Service, 2015-2022 (USD Million)
Table 127 ROW: Liquid Biopsy Circulating Biomarkers Market, By Type,  2015-2022 (USD Million)
Table 128 ROW: Liquid Biopsy Market, By Application, 2015-2022 (USD Million)
Table 129 ROW: Liquid Biopsy Market, By Type of Cancer, 2015-2022 (USD Million)
Table 130 ROW: Liquid Biopsy Market, By Clinical Application, 2015-2022 (USD Million)
Table 131 ROW: Liquid Biopsy Market, By End USer, 2015-2022 (USD Million)
Table 132 Liquid Biopsy Market, By Key Player, 2016
Table 133 CHF to USD Conversion Rates (2014-2016)

List of Figures:
Figure 1 Liquid Biopsy: Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown Of Primary Interviews: By Company Type, Designation and Region
Figure 6 Liquid Biopsy Market, By Product And Service, 2017 Vs. 2022
Figure 7 Liquid Biopsy Market, By Clinical Application, 2017 Vs. 2022
Figure 8 Liquid Biopsy Market, By Application, 2017 Vs. 2022
Figure 9 Liquid Biopsy Market, By End User, 2017 Vs. 2022
Figure 10 Geographical Snapshot Of The Global Liquid Biopsy Market
Figure 11 Increasing Cancer Prevalence—Major Growth Driver For The Liquid Biopsy Market
Figure 12 Therapy Selection Segment To Dominate The Liquid Biopsy Market in 2017
Figure 13 China To Register The Largest Cagr In The Forecast Period For Liquid Biopsy Market
Figure 14 Asia Pacific To Grow At The Highest Cagr During The Forecast Period
Figure 15 Emerging Markets To Grow At Higher Cagrs From 2017 To 2022
Figure 16 Liquid Biopsy Market: Drivers, Restraints, Opportunities, And Challenges
Figure 17 Estimated New Cancer Cases And Estimated Deaths In Us (2017)
Figure 18 Cancer Prevalence And Mortality Rate, By Country (2012)
Figure 19 Pubmed Publications—Liquid Biopsy
Figure 20 Estimated New Cancer Cases And Deaths (2016)
Figure 21 North America: Liquid Biopsy Market Snapshot
Figure 22 US: Cancer Statistics
Figure 23 Canada: Cancer Statistics
Figure 24 Europe: Proportion Of Deaths Due To Cancer In The Eu (2013)
Figure 25 Europe: Deaths Due To Cancer In The Population Aged 65 And Over (2013)
Figure 26 Germany: Cancer Incidence And Prevalence, 2010 Vs. 2015
Figure 27 UK: Estimated Number Of People Living With Cancer
Figure 28 Roe: Incidence And Prevalence Of Cancer, 2015
Figure 29 Asia Pacific: Liquid Biopsy Market Snapshot
Figure 30 Japan: Cancer Incidence And Prevalence Number, 2010 Vs. 2015
Figure 31 China: Cancer Incidence And Prevalence Number, 2010 Vs 2015
Figure 32 India: Cancer Incidence And Prevalence Number, 2010 Vs 2015
Figure 33 Rest Of Asia Pacific: Number Of Cancer Cases, 2015
Figure 34 Liquid Biopsy Market (Global),  Competitive Leadership Mapping 2017
Figure 35 Biocept, Inc.: Company Snapshot (2016)
Figure 36 Qiagen N.V.: Company Snapshot (2016)
Figure 37 Roche Diagnostics: Company Snapshot (2016)
Figure 38 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 39 Myriad Genetics, Inc: Company Snapshot (2016)
Figure 40 Menarini Group: Company Snapshot (2016)
Figure 41 Trovagene Inc.: Company Snapshot (2016)
Figure 42 Mdxhealth: Company Snapshot (2016)
Figure 43 Genomic Health, Inc.: Company Snapshot (2016)
Figure 44 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 45 Illumina Inc.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Mdxhealth Sa
  • Menarini-Silicon Biosystems
  • Myriad Genetics, Inc
  • Qiagen N.V.
  • Raindance Technologies, Inc
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trovagene, Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll